Best Non-Stimulant to Add to Citalopram and Nortriptyline
Bupropion is the best non-stimulant to add to your current regimen of citalopram and nortriptyline, as it provides complementary noradrenergic and dopaminergic activity without increasing serotonergic burden or anticholinergic side effects. 1
Primary Recommendation: Bupropion
- Bupropion (Wellbutrin) should be started at 37.5 mg every morning, increased by 37.5 mg every 3 days, up to a maximum of 150 mg twice daily 1
- This agent is activating and may provide rapid improvement in energy levels, which is particularly useful if apathy or fatigue are prominent symptoms 1
- Give the second dose before 3 PM to minimize insomnia risk 1
- Bupropion is contraindicated in patients with seizure disorders or significant agitation 1
Why Bupropion Works Best in This Context
- You are already on two serotonergic agents (citalopram and nortriptyline), which increases your risk of serotonin syndrome if another serotonergic drug is added 1
- Combining multiple serotonergic medications requires extreme caution, with monitoring especially critical in the first 24-48 hours after dosage changes 1
- Bupropion works through norepinephrine and dopamine reuptake inhibition, providing a different mechanism without compounding serotonergic effects 1
- Nortriptyline already provides noradrenergic activity, but bupropion's dopaminergic effects offer unique benefits for motivation and concentration 1
Alternative Option: Buspirone
If anxiety is a prominent feature alongside depression:
- Buspirone can be added at 20-30 mg/day for augmentation of existing antidepressant therapy 2
- In patients failing to respond to SSRIs (including citalopram), 59% showed complete or partial remission when buspirone was added 2
- 79% of initial responders who remained on buspirone augmentation for at least 4 months were symptom-free at follow-up 2
- Buspirone has minimal drug interactions with your current regimen and no serious side effects were observed in combination therapy 2
Critical Safety Considerations
Serotonin Syndrome Risk
- You are currently on two medications that increase serotonin (citalopram as an SSRI and nortriptyline as a TCA) 1
- Symptoms of serotonin syndrome include mental status changes (confusion, agitation), neuromuscular hyperactivity (tremors, clonus, hyperreflexia), and autonomic hyperactivity (hypertension, tachycardia, diaphoresis) 1
- These symptoms can arise within 24-48 hours after combining medications or increasing doses 1
- Advanced symptoms include fever, seizures, arrhythmias, and unconsciousness, which can be fatal 1
Cardiac Monitoring
- Citalopram can cause QT prolongation at doses exceeding 40 mg/day and should be avoided in patients with long QT syndrome 1
- Nortriptyline also affects cardiac conduction, so ECG monitoring is prudent, especially if you're over 40 years old 3
Anticholinergic Burden
- Nortriptyline has anticholinergic effects (dry mouth, constipation, urinary retention, blurred vision) 3
- Avoid adding medications with additional anticholinergic properties, as this increases risk of confusion, falls, and cognitive impairment 1, 3
What NOT to Add
Avoid Additional Tricyclic Antidepressants
- Never combine nortriptyline with amitriptyline or other TCAs, as nortriptyline is already the active metabolite of amitriptyline 4
- This combination is pharmacologically redundant and increases cardiac toxicity and anticholinergic side effects without additional benefit 4
Avoid Additional SSRIs
- Adding another SSRI to citalopram would be redundant and significantly increase serotonin syndrome risk 1
Avoid MAOIs
- Monoamine oxidase inhibitors are absolutely contraindicated with your current regimen due to severe serotonin syndrome risk 1
Monitoring After Addition
- Assess treatment response after 2-4 weeks at therapeutic doses 3
- Monitor for new or worsening side effects, particularly in the first 24-48 hours after starting or increasing doses 1
- Watch for signs of serotonin syndrome if any serotonergic agent is added 1
- Consider ECG monitoring given the combination of citalopram and nortriptyline 1, 3
If Inadequate Response Persists
- If partial response occurs, consider switching strategies rather than continuing to add medications 5
- After two failed antidepressant trials, switching to a third monotherapy resulted in remission rates below 20% in clinical trials 5
- Consider consultation with psychiatry for more complex augmentation strategies or alternative approaches 5